C-MER Medical Holdings (HKSE:03309) Inventories, Raw Materials & Components: HK$37 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03309 C-MER Medical Holdings Ltd HKSE:03309
83 GF Score
Price HK$0.86
GF Value HK$2.77
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is C-MER Medical Holdings Inventories, Raw Materials & Components?

C-MER Medical Holdings HKSE:03309 -0.58% 83 Inventories, Raw Materials & Components is HK$37 Mil as of Dec. 2025. GuruFocus rates HKSE:03309 with a GF Score™ of 83/100 and a GF Value™ of HK$2.77 (Possible Value Trap). The stock has 5 warning signs investors should review.

C-MER Medical Holdings's inventories, raw materials & components for the quarter that ended in Dec. 2025 was HK$37 Mil.

C-MER Medical Holdings's quarterly raw materials increased from Dec. 2024 (HK$30 Mil) to Jun. 2025 (HK$37 Mil) but then declined from Jun. 2025 (HK$37 Mil) to Dec. 2025 (HK$37 Mil).

C-MER Medical Holdings's annual raw materials increased from Dec. 2023 (HK$23 Mil) to Dec. 2024 (HK$30 Mil) and increased from Dec. 2024 (HK$30 Mil) to Dec. 2025 (HK$37 Mil).

C-MER Medical Holdings Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for C-MER Medical Holdings's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C-MER Medical Holdings Inventories, Raw Materials & Components Chart

C-MER Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.91 38.02 22.67 30.29 36.72

C-MER Medical Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.67 25.58 30.29 37.08 36.72
HKSE:03309
83GF Score
C-MER Medical Holdings Ltd HKSE:03309
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

C-MER Medical Holdings Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of HK$37 Mil mean?
C-MER Medical Holdings (HKSE:03309) has a Inventories, Raw Materials & Components of HK$37 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on C-MER Medical Holdings and its competitors.
Is C-MER Medical Holdings' Inventories, Raw Materials & Components too high?
C-MER Medical Holdings' current Inventories, Raw Materials & Components is HK$37 Mil. Overall, C-MER Medical Holdings has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does C-MER Medical Holdings' Inventories, Raw Materials & Components compare to HCA and THC?
C-MER Medical Holdings' Inventories, Raw Materials & Components of HK$37 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Healthcare Providers & Services company?
A good Inventories, Raw Materials & Components depends on the Healthcare Providers & Services industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on C-MER Medical Holdings and its competitors. C-MER Medical Holdings's current Inventories, Raw Materials & Components is HK$37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-MER Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, C-MER Medical Holdings (HKSE:03309) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.77, compared to a current price of HK$0.86 — trading 69.1% below its estimated fair value. The current Inventories, Raw Materials & Components is HK$37 Mil. C-MER Medical Holdings' overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For C-MER Medical Holdings (HKSE:03309), the current Inventories, Raw Materials & Components is HK$37 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is C-MER Medical Holdings (HKSE:03309) Overvalued in 2026?

Based on GuruFocus' analysis, C-MER Medical Holdings stock appears to be undervalued. The current stock price of HK$0.86 is trading 69.1% below its estimated GF Value™ of HK$2.77. GuruFocus considers C-MER Medical Holdings to be Possible Value Trap.

Key valuation signals for HKSE:03309:

  • Inventories, Raw Materials & Components: HK$37 Mil
  • GF Value™: HK$2.77 vs. price of HK$0.86 (69.1% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the HKSE:03309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

C-MER Medical Holdings Business Description

Address 1-3 Pedder Street, Room 1535, China Construction Building, Central, Hong Kong, HKG
C-MER Medical Holdings Ltd is a ophthalmic medical chain group in Hong Kong and the Greater Bay Area. With ophthalmology as its core, it has gradually expanded its business scope to different specialist services. The company through its subsidiaries are principally engaged in the provision of ophthalmic, dental and other medical services, sales of vision aid products and sales of medical consumables in Hong Kong and Mainland China. Geographically, the company generates revenue from Mailand China, and Hong Kong, with the majority of revenue generated from Mainland China.
83GF Score

Get the complete analysis for HKSE:03309

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.86
Price
HK$2.77
GF Value